Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Molecular Templates Inc.
DescriptionEngineered toxin body (ETB) against CD20
Molecular Target CD20
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationNon-Hodgkin's lymphoma (NHL)
Indication DetailsTreat non-Hodgkin's lymphoma (NHL)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today